Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00211822 · ClinicalTrials.gov registry record
Functional Magnetic Resonance Imaging (fMRI) Studies in Pathological Gambling (PG) and Obsessive-Compulsive Disorder (OCD)
A clinical trial, sponsored by Icahn School of Medicine at Mount Sinai.
- Terminated
- Registry status
- 57
- Enrollment target
NCT00211822 is a clinical trial that was terminated before completion, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 57 participants.
The verdict
NCT00211822 was terminated before completion, sponsored by Icahn School of Medicine at Mount Sinai.
- TERMINATED
- Registry status
- 57 participants
- Enrollment target
Study Summary
This study will explore the brain processes associated with inhibition and reward processing in pathological gamblers and people with obsessive compulsive disorder compared to healthy controls.
Interventions
- PROCEDURE fMRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2004-11 |
| Est. Completion | 2010-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00211822
The ClinicalTrials.gov registry entry for NCT00211822 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 57 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which fMRI is the first listed.
NCT00211822 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00211822 about?
NCT00211822 is a clinical study titled "Functional Magnetic Resonance Imaging (fMRI) Studies in Pathological Gambling (PG) and Obsessive-Compulsive Disorder (OCD)". This study will explore the brain processes associated with inhibition and reward processing in pathological gamblers and people with obsessive compulsive disorder compared to healthy controls.
What is the current status of trial NCT00211822?
This trial is currently terminated. The enrollment target is 57 participants. The study started on 2004-11. Estimated completion is 2010-12.
What interventions are being tested in trial NCT00211822?
The interventions under investigation include: fMRI (PROCEDURE).
Who is sponsoring clinical trial NCT00211822?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.